
Rainbow Childrens Medicare Q4 FY26: Strong Profit Growth Masks Margin Pressure
2026-05-25 09:47:07Rainbow Childrens Medicare Ltd., India's leading paediatric healthcare chain, reported a robust 36.74% year-on-year increase in consolidated net profit to ₹77.04 crores for Q4 FY26, marking the company's highest quarterly profit to date. However, the impressive headline numbers mask underlying margin compression concerns, as operating margins contracted both sequentially and year-on-year despite strong revenue growth of 24.26%. The stock has declined 2.78% following the results announcement, as investors weigh the company's premium valuation of 53x trailing earnings against persistent profitability challenges.
Read full news article
Rainbow Childrens Medicare Ltd is Rated Sell
2026-05-22 10:10:40Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO. This rating was last updated on 22 Sep 2025, reflecting a shift from a previous Hold stance. However, the analysis and financial metrics discussed here represent the stock’s current position as of 22 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Rainbow Childrens Medicare Ltd Technical Momentum Shifts Amid Mixed Signals
2026-05-20 08:05:27Rainbow Childrens Medicare Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day change of 0.05%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting a cautious market sentiment as investors weigh its near-term prospects.
Read full news article
Rainbow Childrens Medicare Ltd is Rated Sell
2026-05-11 10:10:02Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Rainbow Childrens Medicare Ltd Valuation Shifts Signal Elevated Price Risk
2026-05-07 08:02:16Rainbow Childrens Medicare Ltd, a small-cap player in the hospital sector, has seen its valuation parameters shift markedly towards the expensive end of the spectrum, raising questions about its price attractiveness amid sector peers and historical benchmarks. Despite a recent upgrade in market sentiment reflected in a 2.18% day gain, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now position it as very expensive, prompting a reassessment of its investment appeal.
Read full news article
Rainbow Childrens Medicare Ltd is Rated Sell
2026-04-30 10:10:20Rainbow Childrens Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Rainbow Childrens Medicare Ltd Valuation Shifts Signal Heightened Price Risk
2026-04-22 08:01:42Rainbow Childrens Medicare Ltd has seen a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by its elevated price-to-earnings and price-to-book value ratios. Despite this, the stock’s recent returns have been mixed compared to the broader Sensex, prompting a reassessment of its attractiveness for investors within the hospital sector.
Read full news article
Rainbow Childrens Medicare Ltd is Rated Sell
2026-04-19 10:10:14Rainbow Childrens Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Rainbow Childrens Medicare Ltd Valuation Shifts Signal Heightened Price Risk
2026-04-15 08:03:08Rainbow Childrens Medicare Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, raising concerns about price attractiveness amid a challenging market backdrop. Despite recent gains, the stock’s elevated price-to-earnings and price-to-book ratios suggest investors should carefully weigh the risks against potential rewards.
Read full news articleCorporate Action-Board to consider Dividend
23-May-2026 | Source : BSEIntimation for Dividend recommendation.
Announcement under Regulation 30 (LODR)-Change in Management
23-May-2026 | Source : BSEReappointment of Ms. Sundari R. Pisupati
Announcement under Regulation 30 (LODR)-Change in Management
23-May-2026 | Source : BSERe-appointment of Mr. Santanu Mukherjee
Corporate Actions
No Upcoming Board Meetings
Rainbow Childrens Medicare Ltd has declared 30% dividend, ex-date: 27 Jun 25
No Splits history available
No Bonus history available
No Rights history available






